Cross-presentation in viral immunity and self-tolerance.
about
Molecular mimicry, bystander activation, or viral persistence: infections and autoimmune disease.Immune tolerance after delivery of dying cells to dendritic cells in situApoptotic cells deliver processed antigen to dendritic cells for cross-presentationImmature monocyte derived dendritic cells gene expression profile in response to Virus-Like Particles stimulation.Immunity to Pathogens Taught by Specialized Human Dendritic Cell SubsetsCross-Presentation of Cell-Associated Antigens by MHC Class I in Dendritic Cell SubsetsRespiratory dendritic cell subsets differ in their capacity to support the induction of virus-specific cytotoxic CD8+ T cell responses.Optimal Induction of T-Cell Responses against Hepatitis C Virus E2 by Antigen Engineering in DNA ImmunizationCentral tolerance: learning self-control in the thymusSaponin-based adjuvants induce cross-presentation in dendritic cells by intracellular lipid body formationVault nanocapsules as adjuvants favor cell-mediated over antibody-mediated immune responses following immunization of miceEntrapment of H1N1 Influenza Virus Derived Conserved Peptides in PLGA Nanoparticles Enhances T Cell Response and Vaccine Efficacy in Pigs.Poly-γ-glutamic acid/chitosan nanogel greatly enhances the efficacy and heterosubtypic cross-reactivity of H1N1 pandemic influenza vaccineVirus-like particles: a new family of delivery systems.CD40 activation rescues antiviral CD8⁺ T cells from PD-1-mediated exhaustion.Gene expression profile of peripheral blood mononuclear cells in response to HIV-VLPs stimulation.Trogocytosis of MHC-I/peptide complexes derived from tumors and infected cells enhances dendritic cell cross-priming and promotes adaptive T cell responses.Immunological tolerance and tumor rejection in embryo-aggregated chimeric mice - lessons for tumor immunity.Plasmacytoid dendritic cells capture and cross-present viral antigens from influenza-virus exposed cells.Direct presentation is sufficient for an efficient anti-viral CD8+ T cell response.Immune evasion proteins of murine cytomegalovirus preferentially affect cell surface display of recently generated peptide presentation complexes.mRNA vaccine delivery using lipid nanoparticles.EGFRvIII-targeted immunotoxin induces antitumor immunity that is inhibited in the absence of CD4+ and CD8+ T cellsThe potential of adeno-associated viral vectors for gene delivery to muscle tissue.Analysis of phagosomal proteomes: from latex-bead to bacterial phagosomesExosome-driven antigen transfer for MHC class II presentation facilitated by the receptor binding activity of influenza hemagglutininAntigen-specific immune reactions to ischemic stroke.Host immune responses in ex vivo approaches to cutaneous gene therapy targeted to keratinocytes.Mimovirus: a novel form of vaccine that induces hepatitis B virus-specific cytotoxic T-lymphocyte responses in vivoDeletion of the viral anti-apoptotic gene F1L in the HIV/AIDS vaccine candidate MVA-C enhances immune responses against HIV-1 antigensCross-priming.Mouse and human dendritic cell subtypes.Self-antigen presentation by dendritic cells and lymphoid stroma and its implications for autoimmunity.Recombinant yellow fever viruses elicit CD8+ T cell responses and protective immunity against Trypanosoma cruziDendritic cell-based vaccines: barriers and opportunitiesExploiting dendritic cells to improve vaccine efficacy.Critical role of TLR7 signaling in the priming of cross-protective cytotoxic T lymphocyte responses by a whole inactivated influenza virus vaccine.The role of the e3 ligase cbl-B in murine dendritic cells.Free radical theory of autoimmunityInterbilayer-crosslinked multilamellar vesicles as synthetic vaccines for potent humoral and cellular immune responses.
P2860
Q24537348-CC038691-58AC-4195-8445-2208945B9FA8Q24673068-ED3AD647-055B-4D1E-B0BA-039F42DA2B7DQ24791240-4D753DED-A212-476A-9162-A441AF439735Q25257050-B001D103-B99F-4DF5-91F6-F58D80284E2EQ26777195-31C1B691-C9A4-4FC7-9910-C0589AEE948EQ26799991-EE211861-0F81-4E51-ABBC-06FC962E4681Q27438122-7A525FF5-27E4-4ED7-964B-B2FD385B759DQ27485755-C84A1AD5-DC65-43FD-A7E5-C3E7CD2AE260Q28275215-709120F6-B79C-4C8A-BAAB-6D5B6832D32FQ28393754-5FF99F63-B0C4-45E0-B7BC-D17B0BA7BE9EQ28727249-4DD7BC34-3287-47A7-8A74-361F6E6EF0B5Q30387075-4A30C7B6-F84E-4317-9188-813D4228F2B6Q30400146-A2A60EE5-574E-43A5-8751-6ABE162D5F94Q30817169-3A35E956-FA54-4727-9DFF-B2A15EE39DACQ31123164-AB2D919C-FABB-40B5-9926-444A41A6ED97Q33326902-BC9F5A92-487B-4D03-80CA-74E876EC16E9Q33366578-FC263B0B-9619-46E7-BD45-A046D78CC016Q33393451-C54E5BEB-FB73-40CD-8047-114174482CEDQ33505665-142F0FB1-EDF9-459F-99D0-46DEA3132241Q33532640-B4AEF95C-807C-48EF-9FA5-432CFA98D5E2Q33614398-EBBC9F54-AA3A-4DB2-A426-AF739F10B5CBQ33711685-89D3A7DE-92F0-4812-A803-A573ADF5B48AQ33758468-CAAE5BB4-DBCF-460A-9B68-AA02573C3453Q33902499-D4BC46A3-2C5F-4E86-858E-020A664C36D2Q34040311-0BF96348-B3F8-4F5D-8264-9FAB0139DA33Q34147894-CF746592-6210-481E-BB53-5A751501359DQ34171339-9936C372-38F0-4426-A8C8-84A1B5251A7BQ34293796-9864EDDD-9DB1-48E2-A684-1BBD24B3680DQ34348477-D7E2BA9C-C091-483A-AF9D-132F72EFD0FFQ34465228-E7A8FDFD-7E96-4A63-ABBF-F6A3C22637A0Q34503836-D1FB10D4-F78D-4011-AB94-1BFCBCA85270Q34576401-6E8563DA-C2D8-4D97-A754-E670EEC54165Q34590424-46488E77-DAEA-4C2E-8856-9176933C5AA6Q34635043-DCB6803C-CA3E-4065-82C2-272BB8A3E1DFQ34661797-37EA457C-F048-4E9A-9E99-B3989DF00BDCQ34691785-9023FB4D-D264-4772-8318-5841ACEA3224Q34712969-D406A8B9-0ABA-4200-AB85-DE0B18D84FFFQ34769671-28D4D458-B096-4902-AC40-2C3FF6C4467FQ34786280-56253F9D-EE65-41F2-B197-A84979B90A87Q34802680-6CCE695B-5157-4AB5-98DE-51F5CC5EB230
P2860
Cross-presentation in viral immunity and self-tolerance.
description
2001 nî lūn-bûn
@nan
2001 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Cross-presentation in viral immunity and self-tolerance.
@ast
Cross-presentation in viral immunity and self-tolerance.
@en
Cross-presentation in viral immunity and self-tolerance.
@nl
type
label
Cross-presentation in viral immunity and self-tolerance.
@ast
Cross-presentation in viral immunity and self-tolerance.
@en
Cross-presentation in viral immunity and self-tolerance.
@nl
prefLabel
Cross-presentation in viral immunity and self-tolerance.
@ast
Cross-presentation in viral immunity and self-tolerance.
@en
Cross-presentation in viral immunity and self-tolerance.
@nl
P356
P1476
Cross-presentation in viral immunity and self-tolerance
@en
P2093
Carbone FR
P304
P356
10.1038/35100512
P577
2001-11-01T00:00:00Z